Nanoparticle Drug Delivery Systems For Cancer Treatment

Published on 24 Nov, 2015

Nanoparticles in Cancer Treatment

Download this report:     Nanoparticle Drug Delivery Systems For Cancer Treatment

At just 1–100 nanometres in size, Nanoparticles are the next big thing in cancer treatment.

Designed to enter tissues at a molecular level, they can help therapeutic agents pass through biologic barriers, mediate molecular interactions and identify molecular changes.

A bold new platform for cancer diagnostics and therapy, these particles can be used as carriers in a targeted drug delivery approach, minimizing drug-originated systemic toxic effects.

The development and application of engineered nanoparticles to more effectively treat cancer have witnessed significant advancement over the past several decades.

Nanotechnology is a rapidly evolving domain solving various issues associated with conventional drug therapeutics, including poor water solubility, lack of targeting capability, non-specific distribution, systemic toxicity, and low therapeutic index.

Download our report to know more about current research trends and promising new developments in the use of nanoparticles to fight cancer.

Speak your Mind